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Purpose: 
Early and accurate assessment of risk factors present in the pediatric 
patient would minimize morbidity and mortality from venous 
thromboembolism. The purpose of this research was to evaluate the 
reliability and validity of a pediatric venous thromboembolism (VTE) risk 
assessment tool.
Methods:
A pediatric venous VTE risk assessment tool was developed following 
an exhaustive literature review. Random, retrospective chart reviews 
were completed on 1,001 pediatric patients admitted to the pediatric 
inpatient area of Baptist Children’s Hospital who had the risk assessment 
tool completed between November 2008 and November 2009. The tool 
was compared to the patient’s medical record to determine the risk for 
development of VTE. The form was approved by the Department of 
Pediatrics for implementation, and education for the nurses and physicians 
ensured its proper use. Institutional Review Board approval was obtained 
for a study to determine the reliability and validity of the pediatric VTE 
risk assessment tool.
Outcomes:
A total of 1,001 patients were assessed on admission for risk of VTE. 
Results showed 581 of the assessed patients (58 percent) were male, and 
420 (42 percent) of the patients assessed were female, with more than 50 
percent of the patients assessed being younger than 5 years of age. The 
mean age of the patient assessed was 6.91 (± 0.39) years, and the mean 
age by gender distribution was 7.29(± 0.61) years for female patients and 
6.64 years (± 0.5) for male patients.
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Of the 1,001 patients assessed, 981 (98 percent) did not have a VTE 
diagnosis, and 20 (2 percent) patients presented with VTE. Of the 2 
percent with VTE, 14 –– or 70 percent –– were female, indicating a 
relationship between female gender and VTE.
Association between VTE and Gender
Gender Did a Venous Thromboembolism Occur?
       No (0)                         Yes (1)                       
TOTAL
Female 406 (96.7%) 14 (3.3%) 420
Male 575 (99%) 6 (1%) 581
Total 981 20 1,001 
Yates’ Correction for Continuity p=.019
The model was statistically significant, p<.001, indicating the ability to 
distinguish between those patients who would be positive for VTE versus 
negative utilizing the assessment tool. The strongest predictor for the 
development of VTE was that of female gender, recording an odds ratio of 
7.047. This indicates the odds of developing a VTE for females are seven 
times greater than males.
Logistic Regression Predicting VTE Utilizing  
the Pediatric VTE Risk Assessment Tool in  
1,001 Inpatient Chart Reviews
Variables in the Equation
Predictor B S.E. Wald df Sig.
Exp (B)
Odds Ratio
Step 1a Risk Score 1 1.487 0.435 11.656 1 0.001 4.422
Risk Score 2 1.034 0.218 22.589 1 0.000 2.813
Risk Score 3 1.575 0.292 29.014 1 0.000 4.832
Sex (1)
Male: 0 Female:1 1.953 0.738 6.998 1 0.008 7.047
Age 0.100 0.065 2.402 1 0.121 1.105
Constant -7.938 1.081 53.958 1 0.000 0.000
a. Variable(s) entered on step 1: Risk Score 1, Risk Score 2, Risk Score 3, Sex, Age
Test X2 df Sig
Overall Model 100.557 5 <.001
Results showed that the majority of the patients at risk for VTE were 
between 13 and 17 years of age, with females having more than seven 
times greater the risk than males. Data also suggests the higher the 
identified risk score, the greater the risk of VTE demonstrating a 
significant relationship between the risk score and incidence of VTE.
Recommendations:
These preliminary results demonstrate that broad use of this risk assessment 
tool is useful in patients with clinical criteria that may suggest a potential 
risk of VTE as it gives us the probability that the patient may develop VTE. 
Future research recommendations include:
	Prospective risk assessment tool analysis.
	Multi-site studies.
	Implementation of a risk assessment tool on all pediatric patients in order 
to determine risk and initiate treatment.






 states with disseminated
   intravascular coagulation
Total=
                                
•	 Immobility
•	 Obesity	(≥	20%	over	
     IBW)
•	 Use	of	oral		 	 	 	 	
 contraceptives






 of anticoagulant factors   
  
•	 History	of	DVT	(VTE)		 	
 or pulmonary embolism   
 in the past  
Total =
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